LAUSR

Ductal stenting in patients with duct‐dependent pulmonary circulation has allowed growth of pulmonary arteries prior to definitive surgical procedures. Intraprocedural stent thrombosis (IPST) of the arterial duct is a life‐threatening complication as it leads to total circulatory collapse. Previous reports have described use of tissue plasminogen activators in infants for less emergent settings. We report three infants with IPST and the use of tenecteplase to overcome this. Also discussed are the predisposing mechanisms in each scenario and a possibility of direct catheter‐guided tenecteplase administration. Judicious use of tenecteplase can be life‐saving and rapid access to this drug may obviate the need for emergency extracorporeal life support.